Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

The 10 best hospitals for cardiology, heart surgery in the US

The Cleveland Clinic in Cleveland, Ohio, topped this year’s U.S. News & World Report’s list of the best hospitals for cardiology and heart surgery in the country, published at the end of July.

Thumbnail

New Hampshire’s Medicaid work requirement program struck down by judge

A judge has struck down New Hampshire’s Medicaid work requirements program, which requires certain beneficiaries to report work or work-related activities in order to keep their health insurance coverage, in a decision that stemmed from a lawsuit against HHS.

Thumbnail

NIH awards $47M for imaging study investigating lifestyle changes and brain health

The U.S. National Institute on Aging (NIA) has awarded a five-year $47 million grant to the University of California, Berkeley to incorporate imaging into an ongoing study investigating whether lifestyle changes can help protect against dementia.

Thumbnail

Circulation journal names new editor-in-chief

Chris Semsarian, PhD, MPH, has been announced as the newest editor-in-chief of the American Heart Association’s journal Circulation: Genomic and Precision Medicine.

Thumbnail

‘Emotional AI’ helps plastic surgeons give service lines a facelift

Plastic surgeons can apply “emotional AI” algorithms to social media as a way of predicting which specific services will bring in business, according to a study running in the August edition of Plastic and Reconstructive Surgery.

Thumbnail

Pfizer to combine drugs business with Mylan

Pfizer, one of the nation’s largest pharmaceutical companies, is merging its off-patent and generic drug business with Mylan, a global generic and specialty pharmaceutical company based in the Netherlands. The spinoff deal is expected to close mid-2020, pending shareholder and regulatory approvals.

White House prepping another exec order on drug prices

President Trump is reportedly working on another executive order targeting rising drug prices, according to Reuters. 

Going up: ANSTO announces price increase for medical isotopes

The Australian Nuclear Science and Technology Organization (ANSTO) is raising its prices, according to a new report from The Australian.